Roles of LINC01473 and CD74 in osteoblasts in multiple myeloma bone disease

Fengping Peng1, Siyang Yan1, Hui Liu1

  • 1Department of Hematology, Tianjin Medical University General Hospital, Tianjin, China.

Insights

Multiple myeloma (MM) impairs bone health by suppressing osteoblast activity. This study identified specific long non-coding RNAs (lncRNAs) and messenger RNAs (mRNAs) with altered expression in MM patients, revealing potential therapeutic targets.

Area of Science:

  • Molecular Biology
  • Oncology
  • Bone Biology

Background:

  • Osteoblast (OB) dysfunction contributes to multiple myeloma (MM) bone disease.
  • Long non-coding RNAs (lncRNAs) are crucial in bone metabolism, but their role in MM-associated OBs is understudied.

Purpose of the Study:

  • To investigate the expression profiles of lncRNAs and messenger RNAs (mRNAs) in OBs from MM patients.
  • To identify novel molecular targets for addressing bone abnormalities and immune evasion in MM.

Main Methods:

  • High-throughput sequencing of OBs from MM patients and healthy controls.
  • Validation of differentially expressed lncRNAs and mRNAs using quantitative real-time PCR.

Main Results:

  • Identified 22 upregulated and 21 downregulated lncRNAs in MM OBs.
  • Discovered 18 upregulated protein-coding mRNAs.
  • Found elevated LINC01473 and CD74 expression in MM patients, with specific correlations to serum inflammatory markers and lactate dehydrogenase.

Conclusions:

  • Aberrant lncRNA and mRNA expression in OBs from MM patients suggests a role in disease pathogenesis.
  • LINC01473 and CD74 are potential biomarkers and therapeutic targets for MM bone disease and immune escape.
Keywords:
osteoblasts